CNVIF Stock — CNVIF

CNVIF (CNVIF)

Updated October 16, 2026.

CNVIF is a Stock. Total return is -100.0% over the past 17.3 years, 1127.7 points behind SPY at 1027.7%.

Conavi Medical Corp. designs, manufactures, and markets imaging technologies for minimally invasive cardiovascular procedures, including its Novasight Hybrid System that combines intravascular ultrasound and optical coherence tomography for coronary artery imaging. The company is based in Toronto, Canada. Distribution information is not currently available.

CNVIF performance versus SPY

Price and return data through 2026-10-16.

Total return is -100.0% over the past 17.3 years, 1127.7 points behind SPY at 1027.7%. Over the past year its total return — price change plus distributions reinvested — is -81.7%. Its deepest 1-year drawdown was 82.5%.

CNVIF key facts

Asset type

Stock

Asset class

Equity

Inception date

06/26/2009

Distribution frequency

None

Last close

$0.08 (as of 2026-10-16)

Market cap

$11,660,369

Average volume

25000.0

Payout ratio

0.0%

EPS

$-0.17

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

CNVIF risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 82.5%.

Who may consider CNVIF — and who may not

It is a weaker fit for investors who need monthly cash flow (CNVIF does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on CNVIF

• All tickers starting with C

Tagged: Healthcare.

Frequently asked questions